Clinical trials
Asthma clinical trials
A condition where the airways narrow and swell, making breathing difficult. We’re tracking 393 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06981169Recruiting
Using inflammation tests to diagnose asthma in kids and adults
This trial uses a simple inflammation test (inflammometry) to help diagnose asthma more accurately in people aged 6 and older who have been sent by their primary care doctor for standard breathing tests. It aims to improve the diagnosis process and reduce delays.
Montreal, QuebecAges 6 years+ - NCT07011394Recruiting
Better asthma diagnosis for children and teens
This study is testing a new way to diagnose asthma in children and teens using simple breathing tests. If your regular breathing test wasn't clear, this might give a more accurate answer.
Montreal, QuebecAges 6–17 - NCT07059767RecruitingPhase 2
Nasal spray for asthma symptoms from colds
This trial tests if an investigational nasal spray (ETH47) can reduce asthma symptoms triggered by a common cold virus (rhinovirus). You will be exposed to the virus in a safe setting to see if the spray helps control your asthma.
LondonAges 18–65 - NCT07136025Recruiting
Finding treatable traits in severe asthma for personalized care
This study aims to identify specific treatable traits in people with severe asthma and build a personalized treatment plan. It will help doctors understand which treatments might work best for you based on a detailed evaluation.
Beijing, Beijing MunicipalityAges 18–80 - NCT07228026Recruiting
Device to Monitor Asthma by Measuring Nitric Oxide in Breath
This trial tests a handheld device that measures nitric oxide in your breath to see if it can help monitor asthma. You may qualify if you have uncontrolled asthma and can use the device at home.
Stockton, CaliforniaAges 5–100 - NCT07292805Recruiting
Bronchial thermoplasty for severe asthma
This study tests a procedure called bronchial thermoplasty for adults with severe asthma that is not controlled with standard treatments. It aims to see if this can help reduce asthma attacks in people who have already tried or cannot use biologic therapies.
AmsterdamAges 18 years+ - NCT07301060Recruiting
Smartphone app and sensor study for teens with asthma
This study tests if using a special sensor with your inhaler and a smartphone app can help teens with asthma feel better. If you have daily asthma symptoms or use your rescue inhaler often, this study might be for you.
Jacksonville, FloridaAges 13–17 - NCT07679321Recruiting
Anxiety & depression's effect on asthma control
This study looks at how anxiety and depression affect how well asthma medications work. It aims to help predict who might have an asthma attack, so doctors can treat you better.
Changsha, HunanAges 14 years+ - NCT07677059RecruitingPhase 2
Long-term study of KT-621 for asthma patients from previous study
This trial is for people with asthma who already completed a previous study of the drug KT-621. It aims to see if taking KT-621 for a longer time is safe and helpful.
Tampa, FloridaAges 18 years+ - NCT07480616Recruiting
Indonesian asthma breathing exercise for stable asthma
This study tests a special Indonesian breathing exercise program for adults with stable asthma. It aims to see if this routine helps improve your lung function and asthma control.
JakartaAges 18–65 - NCT07486401Recruiting
Blood eosinophil-guided asthma care in primary care
This trial tests whether using a blood test (eosinophil count) to guide asthma treatment works better than usual care for people with mild to moderate asthma. If you have asthma and are on step 1-3 treatment, this study could help improve your symptom control.
SingaporeAges 21–65 - NCT07489911Recruiting
Real-world study of triple inhaler for uncontrolled asthma
This study tests a triple-inhaler called Trimbow for people whose asthma is not well controlled despite using other inhalers. The goal is to see if switching to Trimbow helps reduce asthma attacks and improve day-to-day breathing.
CeljeAges 18 years+ - NCT07500246Recruiting
Better diagnosis and treatment for childhood asthma
This study aims to improve how we diagnose and treat asthma in children. It tests whether a personalized approach can help children whose asthma is not well controlled with current inhaler treatments.
LuxembourgAges 5–16 - NCT07655037Recruiting
Exercise study for severe asthma
This study tests if a personalized exercise program can help adults with severe asthma who are starting a new biologic treatment. It aims to improve symptoms and quality of life.
HelsinkiAges 18 years+ - NCT06811740Enrolling by invitation
Treating severe asthma by focusing on key health issues
This trial looks at people with severe asthma that is hard to control. It aims to find and treat specific health problems that make asthma worse, by doing a detailed check-up and using treatments that are right for you.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07788534Recruiting
FeNO monitoring for children with asthma
This study compares asthma control in children who use a breathing test called FeNO to guide treatment versus a similar group that doesn't. It aims to see if FeNO monitoring helps improve asthma control.
Jeddah, Mecca RegionAges 6–14 - NCT05776927RecruitingPhase 3
Testing a new inhaler for teens with asthma
This trial tests a new combination inhaler (QVM149) against a standard one (Advair) in teenagers with asthma that isn't well controlled by their current medicine. It aims to see if the new inhaler works better.
Tarnów, PolandAges 12–17 - NCT05272241Recruiting
Asthma registry that helps researchers learn about asthma
This study enrolls people in specific cities to collect health information that helps researchers better understand asthma and how to recruit future studies. It may help by improving knowledge about asthma types and care in real-world settings.
Aurora, ColoradoAges Any age - NCT05562466RecruitingPhase 3
Tested inhaler for children with asthma ages 6–11
This Phase 3 study compares a new inhaler (QMF149: indacaterol plus mometasone) against budesonide to see which works better and is safe for children ages 6 to under 12 with asthma. You may be able to join if your child is already on a stable low-dose steroid inhaler and still has symptoms.
CABA, Buenos AiresAges 6–11 - NCT07500974RecruitingPhase 2
L-menthol for breathing difficulty in asthma
This trial tests if L-menthol can help reduce breathlessness in people with asthma. You'll take L-menthol and see if it improves your breathing during exercise.
Karlskrona, Blekinge CountyAges 18 years+ - NCT07768891RecruitingPhase 3
Asthma treatment with combination inhaler
This study tests a new combination inhaler for people with asthma. It may help control symptoms and improve breathing. Participants will either get the study inhaler or a standard treatment, and their asthma will be monitored closely.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07456033RecruitingPhase 3
Depemokimab for adults and teens with type 2 asthma
This study tests a new medicine called depemokimab, given as an injection, to see if it can reduce asthma attacks in people with a specific type of asthma (type 2 high). If you have had asthma for several years and have had recent attacks despite using regular inhalers, this trial might be an option for you.
Little Rock, ArkansasAges 12 years+ - NCT07276724RecruitingPhase 3
Study of GB-0895 for severe uncontrolled asthma
This trial tests an add-on medicine called GB-0895 for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this drug can reduce asthma attacks and improve breathing.
Northridge, CaliforniaAges 12–80 - NCT06023589RecruitingPhase 3
Testing tezepelumab for kids with severe asthma
This study tests if tezepelumab can help reduce severe asthma attacks in children ages 5 to 11. It compares the drug to a placebo (a dummy treatment) to see if it is safe and effective.
Montgomery, AlabamaAges 5–11
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for asthma?
- Yes. Clin2 currently lists 393 recruiting asthma studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a asthma trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a asthma trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.